Q4 and FY2026 Results Presentation
DEEPAKNTR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Deepak Nitrite reported Q4 FY26 revenue of ₹2,127 crore with a strong sequential recovery—EBITDA surged 74% Q-o-Q to ₹383 crore and PAT jumped 120% Q-o-Q to ₹220 crore. However, full-year FY26 shows declining performance: revenue fell 5% to ₹7,947 crore, EBITDA dropped 11% to ₹1,041 crore, and PAT declined 21% to ₹551 crore compared to FY25. Q4 EBITDA margin expanded significantly to 18% from 11% in Q3, driven by cost optimization, favourable product mix, and pricing gains in both Advanced Intermediates and Phenolics segments. The company cited geopolitical disruptions and crude-linked supply chain volatility as challenges but highlighted successful supply chain resilience initiatives including long-term feedstock agreements and backward integration projects.
The sharp Q4 recovery suggests improving operational efficiency and margin resilience despite challenging global conditions. While FY26 full-year declines reflect ongoing pricing pressures in the chemical industry, the margin expansion and 120% PAT growth in Q4 indicate strengthening profitability that could be positive for the stock if sustained into FY27.